| 2005 (%) | 2006 (%) | 2007 (%) | |
| Confirmed histological diagnosis | 65 | 66 | 68 |
| Histology | |||
| NSCLC | 44.8 | 43.9 | 45.5 |
| SCLC | 10.3 | 10 | 9.6 |
| Mesothelioma | 3.7 | 3.5 | 4.2 |
| Discussed at MDT meeting? | 66 | 87 | 91 |
| Any anti-cancer treatment? | 45 | 50 | 52 |
| Overall surgical resection rate | 9 | 9.4 | 10.3 |
| NSCLC resection rate | 13.8 | 14.3 | 15.2 |
| SCLC chemotherapy rate | 57.7 | 61.7 | 64.5 |
| 6-Month survival | 22.3 | 24.6 | 34.7* |
| 1-Year survival | 15.6 | 18.8 | n/a |
*This figure probably overestimates the actual 6-month survival and will fall as more data becomes available. MDT, multidisciplinary team; NSCLC, non-small-cell lung cancer; SCLC, small-cell lung cancer.